Colorectal Adenoma

An investigational blood-based test identified nearly 80% of individuals who had colorectal cancer, according to results of a large prospective trial presented at ASCO Gastrointestinal Cancers Symposium.

An education session at the ASCO Annual Meeting will review strategies to address bias and microaggressions in the medical workplace.

A noninvasive multimodal blood test demonstrated high sensitivity and specificity for the detection of colorectal advanced neoplasia, according to prospective study results presented at Gastrointestinal Cancers Symposium.

A poor-quality diet appeared associated with an increased risk for early-onset, high-risk distal and rectal adenomas, according to study results published in Journal of the National Cancer Institute.

One of the top stories in gastroenterology last week was about a double-blind, randomized clinical trial that showed the Chinese herb Coptis chinensis reduced the risk for recurrent colorectal adenoma.

Omega-3 supplementation of 1 g per day did not appear to reduce the risk for colorectal cancer precursors among the average-risk U.S. population, according to results of an ancillary study of the randomized VITAL trial published in JAMA Oncology.

SAN ANTONIO — In this exclusive video from the American College of Gastroenterology Annual Meeting, Aasma Shaukat, MD, MPH, FACG, professor of medicine at University of Minnesota and GI Section Chief at the Minneapolis VA Medical Center, discusses a major debate in colorectal cancer screening and surveillance.